NuPathe Pharma
http://www.nupathe.com/A specialty pharmaceutical company commercializing ZECUITY® sumatriptan iontophoretic transdermal system (patch) for the acute treatment of migraine. In February 2014, NuPathe was acquired by Teva Pharmaceutical Industries.
Investors 1
| Date | Name | Website |
| - | Bay City C... | baycitycap... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 26.09.2012 | - | $28M | - | Migraine p... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 17.01.2013 | NuPathe ge... | The approval for the Zecuity c... | - | - | medcitynew... |
| 09.10.2012 | Migraine p... | Anido replaced Jane Hollingswo... | - | - | medcitynew... |
| 26.09.2012 | Migraine p... | Armando Anido, the CEO of the ... | - | - | medcitynew... |
| 26.07.2012 | Migraine p... | “My number one priority is c... | - | - | medcitynew... |
| 25.07.2012 | Biopharmac... | Incoming CEO and board member ... | - | - | medcitynew... |
| 16.07.2012 | Migraine p... | Jane Hollingsworth, NuPathe’... | - | - | medcitynew... |
| 19.12.2011 | NuPathe CE... | Six years after NuPathe’s la... | - | - | medcitynew... |
| 29.11.2011 | NB Therape... | Iontophoresis involves using e... | - | - | medcitynew... |
| 15.11.2011 | NuPathe to... | Migraine headaches affect abou... | - | - | medcitynew... |
| 21.02.2011 | New Pittsb... | Promoted Telemedicine’s pot... | - | - | medcitynew... |